Document Detail


N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease.
MedLine Citation:
PMID:  22308119     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: Non-alcoholic fatty liver change is a common disease of the liver in which oxidative stress plays a basic role. Studies are largely focused on protecting the liver by means of anti-oxidative material. The aim of this study is to evaluate the role of N- acetylcysteine in the process of liver injury.
METHODS: Thirty patients with non-alcoholic fatty liver steatosis were randomly selected to receive either N-acetylcysteine or vitamin C. Liver function tests (alanine aminotransfrase, aspartate aminotransfrase and alkaline phosphatase) were measured as well as the grade of steatosis, the pattern of its echogenicity, the span of the liver and the spleen and the portal vein diameter before the intervention. Patients were followed up using the same method of evaluation repeated in the first, second and third months.
RESULTS: The mean age (SD) was 40.1(12.4) in patients receiving NAC and 46(10.4) years in patients receiving vitamin C (P = 0.137). NAC resulted in a significant decrease of serum alanine aminotransfrase after three months, compared to vitamin C. This effect was independent of the grade of steatosis in the initial diagnosis. NAC was able to significantly decrease the span of the spleen.
CONCLUSIONS: N-acetylcysteine can improve liver function in patients with non-alcoholic fatty liver disease. Better results may be achievable in a longer follow up.
Authors:
Manouchehr Khoshbaten; Akbar Aliasgarzadeh; Koorosh Masnadi; Mohammad K Tarzamani; Sara Farhang; Hosain Babaei; Javad Kiani; Maryam Zaare; Farzad Najafipoor
Publication Detail:
Type:  Journal Article     Date:  2010-03-01
Journal Detail:
Title:  Hepatitis monthly     Volume:  10     ISSN:  1735-143X     ISO Abbreviation:  Hepat Mon     Publication Date:  2010  
Date Detail:
Created Date:  2012-02-06     Completed Date:  2012-10-02     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101277874     Medline TA:  Hepat Mon     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  12-6     Citation Subset:  -    
Affiliation:
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Look at the Past History of Hepatitis E in Haiti: Should it be a Warning Sign during the Current C...
Next Document:  Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-...